These differential impacts may be significant and necessary for clinical pathologists to decide whether to report IDC-P subtypes and for surgeons to make reasonable and individualized multimodal therapeutic schedules.
← all excerpts
Intraductal carcinoma of the prostate in prostate biopsy samples: correlation with aggressive pathological features after radical prostatectomy and prognostic value in high-risk prostate cancer.
1
—
—